Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Article

The Tumor Microenvironment Impairs Th1 IFNγ Secretion Through Alternative Splicing Modifications of Irf1 Pre-mRNA

Antoine Bernard, Christophe Hibos, Corentin Richard, Etienne Viltard, Sandy Chevrier, Sophie Lemoine, Joséphine Melin, Etienne Humblin, Romain Mary, Théo Accogli, Fanny Chalmin, Mélanie Bruchard, Paul Peixoto, Eric Hervouet, Lionel Apetoh, François Ghiringhelli, Frédérique Végran and Romain Boidot
Antoine Bernard
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
3Centre Georges François Leclerc, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Hibos
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christophe Hibos
Corentin Richard
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
3Centre Georges François Leclerc, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Etienne Viltard
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandy Chevrier
3Centre Georges François Leclerc, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Lemoine
4Genomic Platform, Institut de Biologie de l’ENS, Paris, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joséphine Melin
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
5LipSTIC LabEx, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Etienne Humblin
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Romain Mary
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Théo Accogli
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fanny Chalmin
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mélanie Bruchard
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
3Centre Georges François Leclerc, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Peixoto
6INSERM UMR1098 “Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique,” Besançon, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Hervouet
6INSERM UMR1098 “Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique,” Besançon, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric Hervouet
Lionel Apetoh
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lionel Apetoh
François Ghiringhelli
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
3Centre Georges François Leclerc, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédérique Végran
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
3Centre Georges François Leclerc, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rboidot@cgfl.fr frederique.vegran@inserm.fr
Romain Boidot
1CRI INSERM UMR1231 “Lipids, Nutrition and Cancer,” Team “CAdIR,” Dijon, Burgundy, France.
2Faculté des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, Burgundy, France.
3Centre Georges François Leclerc, Dijon, Burgundy, France.
7UMR CNRS 6302, Dijon, Burgundy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Romain Boidot
  • For correspondence: rboidot@cgfl.fr frederique.vegran@inserm.fr
DOI: 10.1158/2326-6066.CIR-19-0679
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Additional Files

  • Supplementary Data

    • Supplementary Figures - Supplementary Figures 1-21
    • Supplementary Table - Supplementary Table S1
PreviousNext
Back to top

This OnlineFirst version was published on February 5, 2021
doi: 10.1158/2326-6066.CIR-19-0679

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Tumor Microenvironment Impairs Th1 IFNγ Secretion Through Alternative Splicing Modifications of Irf1 Pre-mRNA
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Tumor Microenvironment Impairs Th1 IFNγ Secretion Through Alternative Splicing Modifications of Irf1 Pre-mRNA
Antoine Bernard, Christophe Hibos, Corentin Richard, Etienne Viltard, Sandy Chevrier, Sophie Lemoine, Joséphine Melin, Etienne Humblin, Romain Mary, Théo Accogli, Fanny Chalmin, Mélanie Bruchard, Paul Peixoto, Eric Hervouet, Lionel Apetoh, François Ghiringhelli, Frédérique Végran and Romain Boidot
Cancer Immunol Res February 5 2021 DOI: 10.1158/2326-6066.CIR-19-0679

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Tumor Microenvironment Impairs Th1 IFNγ Secretion Through Alternative Splicing Modifications of Irf1 Pre-mRNA
Antoine Bernard, Christophe Hibos, Corentin Richard, Etienne Viltard, Sandy Chevrier, Sophie Lemoine, Joséphine Melin, Etienne Humblin, Romain Mary, Théo Accogli, Fanny Chalmin, Mélanie Bruchard, Paul Peixoto, Eric Hervouet, Lionel Apetoh, François Ghiringhelli, Frédérique Végran and Romain Boidot
Cancer Immunol Res February 5 2021 DOI: 10.1158/2326-6066.CIR-19-0679
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Longitudinal Immune Profiling During Cancer Immunoediting
  • Boosting Eomes expression augments anti-tumor immunity
  • IDO1-dependent vascularizing cells at the IFNγ/IL6 interface
Show more Research Article
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement